Valeant Pharma (VRX) says ad hoc committee will review issues brought up in today's WSJ

October 26, 2015 8:43 AM

Valeant Pharma (NYSE: VRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found